Bain Capital Specialty Finance, Inc. BCSF FINANCIAL
Company Overview
Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
Why Investors Should Care
Net profit has compounded at 64.2% per year over the last five years.
Trades at a P/E of 11.8, below the sector median of 12.9.
Maintains a net profit margin of 24.2%.
Offers a dividend yield of 14.45%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -12.1%, earnings -40.8%.
- 5-Year Trend Long-term compounding — profit CAGR 64.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -12.10% |
Compounded Profit Growth
| 5 Years: | 64.18% |
| 1 Year: | -40.80% |
Stock Price Performance
| 1 Year: | -12.11% |
| 6 Months: | -0.60% |
| 3 Months: | -6.45% |
| 1 Month: | -11.29% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)31.09 · Neutral
P/E of 11.75 is below the sector median of 12.89 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 24.2%.
- Profit CAGR of 64.2% over 5 years.
- Attractive dividend yield of 14.45%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BCSF Bain Capital Specialty Finance, Inc. FINANCIAL | 11.63 | 11.75 | $754.42M | 14.45% | - | 5.76% | - | 64.18% |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -104.45M | 21.77M | 51.46M | 39.50M | 31.75M | 42.43M | 23.34M | 22.28M | 33.68M | 17.23M | 11.05M | 43.52M | 29.29M | 29.17M | 33.86M | 31.06M | 35.09M | 29.09M | 33.10M | 22.14M | 28.55M | 23.72M | 18.70M | 27.78M | 3.39M | 14.05M |
| Diluted EPS | -2.02 | 0.40 | 0.80 | 0.61 | 0.49 | 0.66 | 0.36 | 0.35 | 0.52 | 0.27 | 0.17 | 0.67 | 0.45 | 0.45 | 0.52 | 0.48 | 0.55 | 0.45 | 0.51 | 0.34 | 0.44 | 0.37 | 0.29 | 0.43 | 0.05 | 0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Net Income | 8.28M | 119.81M | 105.48M | 123.38M | 119.42M | 98.76M |
| Diluted EPS | 0.14 | 1.86 | 1.63 | 1.91 | 1.85 | 1.53 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.57B | 2.59B | 2.47B | 2.63B | 2.66B |
| Total Equity | 1.02B | 1.07B | 1.10B | 1.12B | 1.14B | 1.14B | 1.12B |
| Cash & Equivalents | - | - | 87.44M | 30.20M | 42.99M | 51.56M | 23.09M |
| Long Term Debt | - | - | 1.41B | 1.39B | 1.26B | 1.39B | 1.47B |
| Total Liabilities | - | - | 1.47B | 1.48B | 1.34B | 1.49B | 1.55B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 89.42M | 265.55M | -316.83M | 219.26M | -27.10M | 29.52M |
| Financing Cash Flow | -76.52M | -138.63M | 238.33M | -231.43M | 14.25M | -71.88M |
| Dividends Paid | - | 87.81M | 87.80M | 99.43M | 114.28M | 145.82M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 0.8% | 10.9% | 9.4% | 10.9% | 10.5% | 8.8% |
| ROCE % | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Bain Capital Credit, LP | 18.23% | 11.82M | $131.11M |
| 2 | Bank of America Corporation | 3.92% | 2.54M | $28.17M |
| 3 | Cresset Asset Management, LLC | 3.69% | 2.39M | $26.56M |
| 4 | UBS Group AG | 2.25% | 1.46M | $16.19M |
| 5 | Van Eck Associates Corporation | 2.12% | 1.38M | $15.29M |
| 6 | Two Sigma Investments, LP | 2.12% | 1.37M | $15.24M |
| 7 | Morgan Stanley | 1.93% | 1.25M | $13.92M |
| 8 | Dimension Capital Management, LLC | 1.93% | 1.25M | $13.90M |
| 9 | Melia Wealth LLC | 1.35% | 872.75K | $9.68M |
| 10 | Muzinich & Co., Inc. | 1.31% | 846.76K | $9.39M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BCSF
Bain Capital Specialty Finance (BCSF) Stock Fair Value Falls As Analysts Cut Outlook - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPOG1BcU5PRWlGLVB3UFNrSXdmeUpDazY3Yjl3R0I5Y29LLTJVaTFCWUZjblBXOTAzVlFuZUNMenFaUU5XQk1ydzBJWEdEQWxUWjZnOU1jTF9uX1preGZCT2hNQXdOQXJhSHBZSEpvOTNDR2hHckdwVVhaTDRCbTRNb2JBVHZOeXNwbm9TeW…
Bain Capital Specialty Finance (NYSE:BCSF) Hits New 1-Year Low - Should You Sell? - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPVC1aODRMb2QtR2VUNjV5anlRNndVdHpiVDlBdjZfYUxXMVM1SXNVendpZlRaS1drSnFTLWJSZ3I4VlNLV2NWcXlEUHlCR0dZYXN6SW1Lb3BqazNRY2s4UzVNci1NMmJvVl9MZ1V1dEpHYTV5WkZNdGFWNHFoWlhTZ2VBaEw3UjZTMlY0Wl…
Bain Capital Specialty Finance (BCSF) Stock Sees Fair Value Cut After Q1 Analyst Revisions - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPMDRsTGR5b2kyYlBlVmF1S19lc3FzRDBQSE1LMVZDbkZlSDZETDFXVWRNMEdSc0I2T2dQYUxMN0N0TVl4cE5aMk54VFBhaWlTSnVvanQyaXI1RUM2NmktNklfZnVBYkZrYklMUFBWZXd4QnpiNm5XSnZQRXNKelF0OXdud0JKNFF3eXFRRX…
Understanding Momentum Shifts in (BCSF) - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQT21EUXUwWFFOQ05DRnJySTdQMlFVRWNEdzJmcE5QXzFnTXdCYTd5RUlFV184TXg0Mi1GTVgzM0xJb0FJYTdyZnVLZEFRZG1vdVZxYXR5TXRRdGtlcEpuUGtwUnltXzktUHBKczNEcWdTUlRVVmM2NmRXb2FDdlFqcG1BNVM1VkNKOXhYVk…
BAIN CAP SPECIALTY FIN Q2 2026 Earnings Preview: Recent $BCSF Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxPWElDbi1zOFJGSEFkRXhPYkNWVy1qdVRnd3VySDM2WUQ4QVhFams0WTRTLVhidktzN3hhX0x2cVRJV3lDRTJTNWd1TUtnOU9PanFnWk1VSnhOOEswS0lNSVUxY0RUNGktS3lZbUpnYnJES05taW9sUzN6bHU1UFdyT1FMTTFWeERCSnRGa0…
Bain Capital Specialty Finance: Deep Discount, Strong Returns - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbG1CQndrQXBWU1V2eGMyMHhFZ0xHVGxKeGUxcF9CLTFpd2I1eFZxS1BQWGFQUVhDRDBpam5qa1JZbXNpZ2NpczZ0aTBmMGVkb2RMYlA1YjNEX3pxa0NqVXBrSUNPZm9qeWg0SnhHUVMtMFRHTzJtVUZuVzUzbWdKd1pBcUhDMThGT0xuRl…
BCSF — Frequently Asked Questions
What is the current share price of Bain Capital Specialty Finance, Inc. (BCSF)?
As of 2026-09-19 21:16 PDT, Bain Capital Specialty Finance, Inc. (BCSF) trades at $11.63 on NYSE. Its 52-week range is $11.52 to $13.74.
What is the market capitalisation of BCSF?
Bain Capital Specialty Finance, Inc. (BCSF) has a market capitalisation of $754.42M on NYSE.
What is the P/E ratio of BCSF?
BCSF trades at a trailing price-to-earnings (P/E) ratio of 11.75. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is 0.69.
Does BCSF pay a dividend?
Bain Capital Specialty Finance, Inc. (BCSF) currently offers a dividend yield of 14.45%.
What is the return on equity (ROE) of BCSF?
BCSF has a return on equity (ROE) of 5.76%.
Is BCSF a good stock to buy?
This page provides a data-driven analysis of Bain Capital Specialty Finance, Inc. (BCSF), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.